Autres langues Verve Therapeutics, Inc.

Actions

VERV

US92539P1012

Temps réel estimé Cboe BZX Autres places de cotation 20:31:43 16/05/2024			Varia. 5j.	Varia. 1 janv.
6,345 ^USD	+1,85 %		-0,16 %	-54,45 %

08/05	Verve Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
07/05	Verve Therapeutics annonce le dosage du premier patient de l'essai clinique de phase 1b Heart-2 évaluant le VERVE-102	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Verve Therapeutics CFO Andrew Ashe Executes Purchase of 76,000 Shares of Common Stock; Shares Jump Premarket	13:05
Verve Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Verve Therapeutics: Q1 Earnings Snapshot	08/05
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results	08/05
Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102	07/05
Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102	07/05
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	03/05
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws	19/04
Sector Update: Health Care Stocks Slide Late Afternoon	02/04
Top Midday Decliners	02/04
Looming Factory Orders, Job Openings Data Prompt Lower Premarket Action for US Equity Futures	02/04
Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday	02/04
Sector Update: Health Care	02/04
Verve Therapeutics Pauses Heart-1 Trial After Serious Adverse Events; Shares Fall Pre-Bell	02/04
Top Premarket Decliners	02/04
Verve Therapeutics Announces Updates on its PCSK9 Program	02/04
Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels	02/04
Verve Therapeutics, Inc. Announces Updates on its PCSK9 Program	02/04
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	28/03
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	01/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Verve Therapeutics, Inc.

Actions

VERV

US92539P1012

Autres langues

Filtres